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The rate of collapse of a proton gradient across the apical membrane of rat kidney proximal tubule increases upon treat- 
ment with calcium, mercuric chloride and mellitin, substances which activate phosphohpase A,. Treatment with phospho- 
lipase A, or oleic acid also enhances the rate of proton gradient dissipation. Membrane water permeability is not affected. 
This phenomenon may have implications in pathological states arising from ischemia or toxic exposure. 
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1. INTRODUCTION 
Maintenance of proton gradients in cellular 
systems is essential for normal cellular 
homeostasis. For example, if the proton gradient 
in the mitochondria is dissipated, the cell cannot 
produce ATP and the cell will eventually die. Con- 
sequently, factors which increase proton 
permeability in biological membranes may also be 
factors which lead to disintegration of cellular 
homeostasis via disruption of cellular energy 
transduction. 
We have used the isolated biological membrane 
system, brush border membrane vesicles (BBMVs) 
obtained from the proximal tubule of rat kidney, 
to show that intravesicular calcium ion, in- 
travesicular mercuric ion, fatty acids and ex- 
ogenous phospholipase A2 all increase proton 
permeability of the plasma membrane. These fac- 
tors may be significant in mechanisms of necrotic 
cell death. 
2. MATERIALS AND METHODS 
BBMVs were obtained from rat kidneys and isolated by dif- 
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ferential centrifugation using the magnesium-precipitation 
method [I] to prevent inadvertent activation of phospholipases 
by calcium [2]. Vesicles were used within 4 h of preparation, 
and not frozen in order to avoid freeze-thaw activation of en- 
dogenous phospholipase [3]. 
Proton transport was monitored by acridine orange 
fluorescence [4]. Water transport was measured as described 
previously [S]. 
Membrane fatty acids were extracted from BBMVs with 
methanol/hexane/l M phosphoric acid (3:g: I by vol.). The 
hexane phase was washed twice with 0.1 M phosphoric acid. 
The fatty acids were back extracted into 0.01 volume of 0.5 M 
KOH, esterified with dimethylacetamide and methyl iodide, 
and analyzed by gas chromatography using pentadecanoic acid 
as an internal standard. 
3. RESULTS 
Addition of 1.8 mM calcium to the ex- 
travesicular solution did not change the rate of 
dissipation of the proton gradient in BBMVs 
(fig.1). However, in the presence of the calcium 
ionophore, A23187, calcium increased the rate 
substantially. By comparison, A23187 alone had 
only a slight protonophoric effect. Since BBMV 
membrane has a low baseline permeability to 
calcium ion, and addition of A23187 will equalize 
the intravesicular and extravesicular calcium con- 
centrations [6], these experiments demonstrate that 
intravesicular calcium increases the proton 
permeability of the BBMV membrane. 
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Fig. 1. Rates of collapse of the proton gradient. BBMVs were 
suspended to 0.3 mg protein/ml in 190 mM mannitol, 50 mM 
choline chloride, 10 mM Hepes, 6 PM acridine orange, pH 6.0, 
then mixed in a stopped-flow photometer with an equal volume 
of an identical buffer but at pH 9.0, producing a final 
extravesicular pH of 7.5. The acridine orange fluorescence 
100 ms after mixing was described well by a single exponential 
function; the exponential rate constant, obtained by non-linear 
least squares analysis, is expressed relative to control. 
Treatments were 1.8 mM CaCl2, 10/M A23187, 100pM 
MnC12, S pM HgCl2, 0.5 bg/ml melittin and 0.1 pg/ml porcine 
pancreatic phospholipase AZ (PLAz) for 2 h at 25°C. 
A23187 is known to catalyze Ca2+-H+ exchange 
directly [7]; however, this exchange cannot ac- 
count for the observed increase in proton 
permeability. The proton efflux experiments were 
done such that there was an outwardly-directed 
calcium gradient. If A23 187-catalyzed Ca2+-H’ 
exchange was operative in our system, then 
A23187 would enhance proton influx, leading to a 
decrease in the rate of proton efflux. We observed 
an increase in proton efflux rate; therefore, if 
anything, our data may represent an underestimate 
of the true effect of intravesicular calcium. 
Calcium is known to activate phospholipases 
[S]; we investigated the relation between an in- 
crease in intracellular calcium and enhanced 
phospholipase activity by measuring the effect of 
intravesicular divalent manganese on the calcium- 
induced enhancement of the proton permeability. 
Calcium-stimulated phospholipase activity can be 
inhibited by manganese [8]. Fig.1 shows that in- 
travesicular manganese also inhibits the enhance- 
ment in proton permeability. 
Divalent mercury, a calcium-mimetic activator 
of phospholipase [9], increased the proton 
permeability of BBMVs by 5.7-fold after a 2 h 
treatment (fig. 1). Intravesicular manganese 
resulted in an inhibition of the mercury-induced 
enhancement. Similar effects of mercury and 
manganese on phospholipase activity have been 
reported in a cultured mouse fibroblast system [9]. 
That calcium and mercuric ions do indeed ac- 
tivate phospholipase in BBMVs was demonstrated 
by measuring the fatty acid content of the mem- 
brane subsequent to treatment. In two ex- 
periments, treatment with 2 mM Ca2+, under 
conditions producing the increases in proton 
permeability seen in fig. 1, increased the amount of 
oleic and arachidonic acids by factors of 2.9 and 
5.6, respectively, over control values. Treatment 
with 5 ,uM Hg2+ increased the amount of oleic acid 
by 2.7 over control, while the concentration of 
arachidonic acid was relatively unaffected. 
Melittin, isolated from bee venom, is a potent 
phospholipase activator [lo]. Vesicles treated with 
melittin had a passive proton permeability four 
times greater than control. Treatment of the 
vesicles with exogenous pancreatic phospholipase 
A2, which catalyzes the hydrolysis of phos- 
pholipids into free fatty acids and lysophos- 
phatides, enhanced the dissipation rate of a proton 
gradient by a factor of 13 (fig.1). 
These experiments suggest that enhanced 
phospholipase activity results in an increase in the 
proton permeability of BBMVs. A biochemically 
important product of phospholipase activity is 
fatty acids, since pharmacological effects of 
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Fig.2. Oleic acid addition enhances proton permeability. 50 pl 
of a stock solution of oleic acid in ethanol were added to 50 ml 
of 0.3 mg/ml BBMV suspension and homogenized with a glass- 
teflon homogenizer. The rate of dissipation of a proton 
gradient was measured as described in the legend to fig.1. 
Treatment with ethanol alone had no effect on the dissipation 
rate. 
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Fig.3. Osmotic water permeability of BBMVs is not affected by 
treatments affecting proton permeability. 
phospholipase AZ resemble those produced by high 
concentrations of fatty acids [l 11. The effect of 
fatty acids on the rate of dissipation of proton gra- 
dients was examined by adding oleic acid directly 
to the BBMV suspension. A dose-dependent in- 
crease in the proton permeability was observed 
(fig.2). 
The possibility that the increase in proton 
permeability seen with calcium, mercury, melittin, 
phospholipase AZ and oleic acid was a result of a 
general disruption of the BBMV membrane rather 
than a result of protonophoric activity mediated by 
fatty acids was tested by measuring the effect of 
these agents on the osmotic water permeability of 
the vesicles. The data (fig.3) indicate that no 
significant differences exist between the ex- 
perimental groups and the control group during 
the time that the same treatment produced marked 
enhancements in proton permeability. These ex- 
periments indicate that proton transport is en- 
hanced before the membranes become disrupted or 
lysed. For instance, melittin at high concentrations 
has been reported to disrupt phospholipid bilayer 
membranes [12], presumably causing a large in- 
crease in water permeability. Our experiments in- 
dicate that melittin-treated BBMV membranes had 
a water permeability identical to control, but with 
much higher proton permeability, suggesting that 
phospholipase activation is the predominant effect 
of melittin at the dose employed. 
4. DISCUSSION 
Taken together, our results indicate that the rate 
of dissipation of a proton gradient in BBMVs can 
be enhanced by the incorporation of fatty acids in- 
to the membrane, either by activation of 
phospholipases or by direct addition of fatty acids. 
Because of the basic structural similarity of 
biological membranes, our results suggest that pro- 
ton gradients in other biological membranes can 
also be dissipated by these agents. Our results do 
not give direct insights into the mechanism for the 
baseline proton permeability of biological mem- 
branes, but indicate that the permeability can be 
enhanced above this level by incorporation of fatty 
acids into the membrane. 
Several recent reports in the literature indicate 
that the factors we have found which increase fatty 
acid concentration in BBMVs have similar effects 
in other membrane systems. An increase in the in- 
tracellular calcium ion concentration results in an 
increase in free fatty acids in a cultured fibroblast 
system [8,13]. Exposure of cultured LLC-PKi cells 
to 50 PM HgCl2 for 30 min results in an increase of 
lysophosphatides and free fatty acids and a con- 
comitant decrease in phospholipid, presumably by 
mercuric activation of phospholipase A [ 14,151. 
Our data indicate that an increase in fatty acid con- 
centration leads to an increase in BBMV proton 
permeability; addition of fatty acids also increases 
membrane proton permeability in lipid bilayers 
[ 161, presumably by the carrier mechanism pro- 
posed for protonophoric effects of other weak 
acids [17-191. 
Fatty acids are known uncouplers of oxidative 
phosphorylation in mitochondria [20,21]. The un- 
coupling effect at high fatty acid concentration 
may be due to the increase in the proton 
permeability of the inner mitochondrial mem- 
brane, leading to dissipation of proton gradients 
and inability to drive ATP synthesis according to 
the chemiosmotic hypothesis [22]. Therefore, the 
distinct possibility exists that any insult to a living 
cell that would increase the fatty acid content of 
mitochondrial membranes would have severe 
pathological consequences. 
Ischemia may be such an insult. In a rat liver 
system, mitochondrial free fatty acid concentra- 
tion increases soon after the onset of ischemia [23]. 
Addition of bovine serum albumin, a fatty-acid 
scavenger, protects against the loss of 
phosphorylation capability. In rat kidney, the 
ischemia-induced increase in mitochondrial fatty 
acid content is correlated with a progressive loss of 
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oxidative phosphorylation capability [24]. Similar 
results correlating activation of phospholipase or 
elevated levels of fatty acid with ischemic insult 
have been obtained with perfused rat hearts [25], 
cultured myocardial cells [26], rat livers in vivo 
[27], dog hearts in vivo [28,29], and perfused pig 
kidneys [30]. 
The key irreversible step in cell death has not 
been specified on a molecular level. Our data and 
various reports in the literature suggest that the key 
step may be an accumulation of fatty acids in the 
mitochondrial membrane which dissipate the pro- 
ton gradients necessary for ATP synthesis. In 
ischemia, the fatty acid concentration would in- 
crease via activation of phospholipases triggered 
by the rise in intracellular calcium concentration 
seen in dead and dying cells [ 13,3 1,321; in mercury 
toxicity, the phospholipases would be activated 
directly by intracellular mercuric ion [9]. Fatty 
acids may have a dual pathogenic role in ischemia 
because of their ability to increase the calcium 
permeability of biological membranes [33,34]. 
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